» Authors » Ingrid Hougen

Ingrid Hougen

Explore the profile of Ingrid Hougen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 104
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Noel J, Hougen I, Sood M
Front Neurol . 2022 Jul; 13:823569. PMID: 35800082
Impairment in cognition and decline in kidney function often converge in the aging individual with chronic kidney disease (CKD). Cognitive impairment (CI) may be preventable through modification of health behaviors...
2.
Leon S, Trachtenberg A, Briscoe D, Ahmed M, Hougen I, Askin N, et al.
J Pharm Technol . 2022 Feb; 38(1):54-62. PMID: 35141728
Opioid analgesics are among the most commonly prescribed medications, but questions remain regarding their impact on the day-to-day functioning of patients including driving. We set out to perform a systematic...
3.
Hougen I, Whitlock R, Komenda P, Rigatto C, Clemens K, Tangri N
BMJ Open Diabetes Res Care . 2021 Dec; 9(2). PMID: 34969692
Introduction: Metformin is the initial oral antihyperglycemic agent (OHA) of choice for most patients with type 2 diabetes (T2D). However, more than one agent is often required for optimal glucose...
4.
Hougen I, Leon S, Whitlock R, Rigatto C, Komenda P, Bohm C, et al.
Kidney Int Rep . 2021 May; 6(5):1309-1316. PMID: 34013109
Introduction: Hyperkalemia is a common, potentially life-threatening condition in patients with chronic kidney disease (CKD). We studied the association between hyperkalemia and mortality, cardiovascular events, hospitalizations, and intensive care unit...
5.
Whitlock R, Hougen I, Komenda P, Rigatto C, Clemens K, Tangri N
Mayo Clin Proc . 2020 Jan; 95(1):90-100. PMID: 31902433
Objective: To compare the safety of metformin vs sulfonylureas in patients with type 2 diabetes by chronic kidney disease (CKD) stage. Patients And Methods: This retrospective cohort study included adults...
6.
Hougen I, Collister D, Bourrier M, Ferguson T, Hochheim L, Komenda P, et al.
Clin J Am Soc Nephrol . 2018 Feb; 13(3):457-467. PMID: 29463597
Background And Objectives: The safety of intravenous iron dosing in dialysis is uncertain. Higher-dose intravenous iron may be associated with a higher risk of infections, cardiovascular events, hospitalizations, and mortality....
7.
Tangri N, Hougen I, Alam A, Perrone R, McFarlane P, Pei Y
Can J Kidney Health Dis . 2017 Mar; 4:2054358117693355. PMID: 28321323
Purpose Of Review: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder characterized by the formation of kidney cysts and kidney enlargement, which progresses to kidney failure by the...